Sodium-Glucose Cotransporter-2 Inhibitor Use is Associated with a Reduced Risk of Heart Failure Hospitalization in Patients with Heart Failure with Preserved Ejection Fraction and Type 2 Diabetes Mellitus: A Real-World Study on a Diverse Urban Population.

Li, Weijia; Katamreddy, Adarsh; Kataria, Rachna; Myerson, Merle L; Taub, Cynthia C

Li, Weijia; Katamreddy, Adarsh; Kataria, Rachna; Myerson, Merle L; Taub, Cynthia C.

Afiliação

Li W; Department of Medicine, Jacobi Medical Center/Albert Einstein College of Medicine, The Bronx, NY, USA.
Katamreddy A; Department of Medicine, Jacobi Medical Center/Albert Einstein College of Medicine, The Bronx, NY, USA.
Kataria R; Division of Cardiology, Montefiore Medical Center/Albert Einstein College of Medicine, The Bronx, NY, USA.
Myerson ML; Section of Cardiovascular Medicine, Dartmouth-Hitchcock Medical Center, Geisel School of Medicine, 1 Medical Center Drive, Lebanon, NH, 03756, USA.
Taub CC; Division of Cardiology, Montefiore Medical Center/Albert Einstein College of Medicine, The Bronx, NY, USA. cynthia.c.taub@hitchcock.org.

Drugs Real World Outcomes ; 9(1): 53-62, 2022 Mar.

Article em En | MEDLINE | ID: mdl-34478119

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Etiology_studies / Risk_factors_studies Idioma: En Revista: Drugs Real World Outcomes Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos País de publicação: Suíça

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google